Metabolic changes of anterior cingulate cortex in patients with hepatic cirrhosis: A magnetic resonance spectroscopy study

Hepatology Research

Volumn 40, Issue 8, 2010, Pages 777-785

  Zhang, Long Jiang ^a   Lu, Guang Ming ^a   Yin, Jian Zhong ^b   Qi, Ji ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Cingulate cortex; Hepatic cirrhosis; Hepatic encephalopathy; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

AMMONIA; CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL;

ADULT; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 77955249606     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00681.x     Document Type: Article

References (31)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-21.
2. Zhang LJ, Yang G, Yin J, Liu Y, Qi J. Neural mechanism of cognitive control impairment in patients with hepatic cirrhosis: a functional magnetic resonance imaging study. Acta Radiol 2007, 48:577-87.
3. Zhang LJ, Yang G, Yin J, Liu Y, Qi J. Abnormal default-mode network activation in cirrhotic patients: a functional magnetic resonance imaging study. Acta Radiol 2007, 48:781-7.
4. Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol 2008, 29:1612-21.
5. Stewart CA, Reivich M, Lucey MR, Gores GJ. Neuroimaging in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005, 3:197-207.
6. Miese F, Kircheis G, Wittsack HJ. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. Am J Neuroradiol 2006, 27:1019-26.
7. Córdoba J, Alonso J, Rovira A. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001, 35:598-604.
8. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994, 9:347-59.
9. Rovira A, Córdoba J, Raguer N, Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr Opin Neurol 2002, 15:731-7.
10. Spahr L, Vingerhoets F, Lazeyras F. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000, 119:774-81.
11. Tarasów E, Panasiuk A, Siergiejczyk L. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. Hepatogastroenterology 2003, 50:2149-53.
12. Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB. Minimal hepatic encephalopathy in children: evaluation with pProton MR spectroscopy. Am J Neuroradiol 2009, 30:1610-13.
13. Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS. Anterior cingulate conflict monitoring and adjustments in control. Science 2004, 303:1023-6.
14. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 2003, 100:253-8.
15. Mechtcheriakov S, Schocke M, Kugener A. Chemical shift magnetic resonance spectroscopy of cingulated grey matter in patients with minimal hepatic encephalopathy. Neuroradiology 2005, 47:27-34.
16. Binesh N, Huda A, Bugbee M. Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaing 2005, 21:398-405.
17. McIntyre N. Ascites and portal hypertension. Oxford Textbook of Medicine 1987, 12236-44. Weatherall DJLedingham JGGWarell DA. In, eds., Oxford, Oxford University Press
18. Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol 1995, 10:14-23.
19. Laubenberger J, Haussinger D, Bayer S, Gufler H, Kennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1996, 112:1610-16.
20. Köstler H. Proton Magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab Brain Dis 1998, 13:291-301.
21. Ross BD, Jacobson S, Villamil F. Subclinical hepatic encephalopathy: protonMR spectroscopic abnormalities. Radiology 1994, 193:457-63.
22. Chamuleau RA, Vogels BA, Bosman DK, Bovée WM. In vivo brain magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in hepatic encephalopathy. Adv Exp Med Biol 1994, 368:23-31.
23. Geissler A, Lock G, Fründ R. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997, 25:48-54.
24. Lee JH, Seo DW, Lee YS. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am J Gastroenterol 1999, 94:2206-13.
25. Jalan R, Olde Damink SW, Hayes PC, Wardlaw JM. Diagnosis of hepatic encephalopathy: will in vivo MRS play a role? Hepatology 1999, 29:1605-7.
26. Sawara K, Kato A, Yoshioka Y, Suzuki K. Brain glutamine and glutamate levels in patients with liver cirrhosis: assessed by 3.0-T MRS. Hepatol Res 2004, 30:18-23.
27. Weissenborn K, Heidenreich S, Ennen J, Rückert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001, 16:13-19.
28. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001, 34:768-73.
29. Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umiltà C. Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 2005, 20:115-27.
30. Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. Am J Neuroradiol 2005, 26:347-51.
31. Butterworth RF. Taurine in hepatic encephalopathy. Adv Exp Med Biol 1996, 403:601-6.